Michael Goller, Ph.D.

Chief Project Officer

Michael Goller, Ph.D. is a globally recognized leader in the field of respiratory pharmaceutical product development, with an international career spanning more than twenty years at Sandoz, Lupin, Teva, Chemo, IVAX and Quadrant Healthcare.

Dr. Goller has directed multiple projects that led to filings and approvals in the US, UK/EU, across all major drug delivery systems (DPI, MDI, SMI and nebules) and drug classes (SABA, LABA, LAMA, ICS and combinations).

As Chief Project Officer, Dr. Goller is responsible for Transpire Bio’s product development strategy and project management, delivering a pipeline of respiratory products, improving patient access to affordable medicines and providing treatment options where there is unmet need.